Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06534450
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-07-17
Brief Title:
The Effects Of Therapeutic Plasma Exchange TPE On Age Related Biomarkers And Epigenetics
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Comparative Randomized Placebo Sham Pheresis Controlled Clinical Trial To Evaluate The Effects Of Therapeutic Plasma Exchange TPE On Age Related Biomarkers And Epigenetics
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to assure the safety of long term therapeutic plasma exchange TPE with and without Intravenous Immunoglobulin IVIG and its effects on biomarkers and epigenetic biologic clocks in forty individuals The main question is to assure the safety from long term TPE using changes in clinical and laboratory outcomes and also evaluating changes on additional blood biomarkers and epigenetic clocks during and after TPE treatment Researchers will compare the TPE treatment group to the Sham treatment group to identify changes due to TPE Participants will receive six TPE or Sham treatments over one of two treatment schedules and may receive IVIG with treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None